FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer By Ogkologos - September 19, 2025 548 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Cohort 2 of SunRISe-1 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence MOST POPULAR Young Mom Battles Breast Cancer After Being Misdiagnosed with a Blocked... July 30, 2019 Reunión anual de la American Society of Clinical Oncology de 2022:... June 5, 2022 Tips On Staying Cool During a Heat Wave June 30, 2021 Bjorn Saven: “By supporting early career researchers to do their jobs... November 19, 2021 Load more HOT NEWS Approval Expanded for Venetoclax in Chronic Lymphocytic Leukemia After Misdiagnosis, Mom Found Out She Had Terminal Breast Cancer Shortly... After Battling Breast Cancer and Infertility, Mom Welcomes Miracle Baby Aspartame and cancer – sweet nothings?
